Lexotanil

Bromazepam, the active ingredient in Lexotanil, is a benzodiazepine presented as an oral tablet for systemic use. It is prescribed to manage anxiety disorders and related conditions in adult patients, acting as a central nervous system depressant to reduce excessive neuronal activity.

GNH USA supplies Lexotanil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Clients benefit from comprehensive regulatory support and timely delivery across multiple continents.

Bromazepam is a benzodiazepine indicated for anxiety‑related conditions.

- Generalized anxiety disorder: reduces excessive worry and tension. - Panic disorder: alleviates acute panic attacks. - Pre‑operative anxiety: provides calming effect before surgical procedures.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Impaired coordination: reduced motor control and balance. - Memory impairment: difficulty recalling recent events.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with other depressants. - Paradoxical agitation: unexpected increase in anxiety or aggression. - Dependence and withdrawal seizures: risk of physical dependence with abrupt discontinuation. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, swelling, or anaphylaxis.

Before initiating therapy, consider the following precautions: - Assess renal and hepatic function: adjust use in patients with impairment. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. - Use caution in elderly: increased sensitivity to sedation and falls. - Avoid concomitant CNS depressants: risk of additive sedation and respiratory depression. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Bromazepam may interact with several drug classes. Monitor patients closely and avoid certain combinations.

Major Interactions (Avoid): - Opioids: additive respiratory depression and profound sedation. - Barbiturates: heightened central nervous system depression. - Alcohol: enhanced sedation, impaired psychomotor function.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase overall sedation. - Antihistamines: potential for increased drowsiness. - CYP3A4 inhibitors (e.g., ketoconazole): may raise bromazepam plasma concentrations.